This is an HTML version of an attachment to the Freedom of Information request 'Covid-19 vaccines'.


 
 
Department Reference: FOI 3421 
 
 
Christopher Thanos 
via email: xxxxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxxxx.xxx.xx 
 
 
Dear Mr Thanos 
 
NOTICE OF DECISION UNDER SECTION 24A 
OF THE FREEDOM OF INFORMATION ACT 1982 
 
I refer to your request of 29 November 2021 to the Department of Health (the 
department) seeking access under the Freedom of Information Act 1982 (Cth) (the  
FOI Act) to the following documents:  
 
I was wondering how many vials/doses of the SARS- COVID 19 vaccines (including 
Pfizer, AZ, Moderna, JJ etc) have been purchased to help fight the delta variant of this 

disease. 
 
Information about COVID-19 vaccines 
 
The Australian Government has invested over $9 billion in the national COVID-19 
vaccine rollout and is rolling out several approved vaccines.  
 
Australia has supply agreements in place for the Comirnaty (Pfizer), Spikevax 
(Moderna) and Vaxzevria (AstraZeneca) vaccines, which are TGA approved and 
available now. However, those agreements do not relate to any specific variant of the 
COVID-19 virus. 
 
Additional information about the COVID-19 vaccines, including the vials and doses 
purchased, is available on the department’s website here: 
www.health.gov.au/initiatives-and-programs/covid-19-vaccines/about-
rollout/vaccine-agreements 
 
 

 
Freedom of Information Unit (MDP 516)  GPO Box 9848 Canberra ACT 2601 
Telephone: (02) 6289 1666  ABN: 83 605 426 759 


FOI decision 
 
I am authorised under subsection 23(1) of the FOI Act to make decisions in relation 
to Freedom of Information requests. I am writing to notify you of my decision in 
response to your request. 
 
Appropriate steps have been taken to find the documents referred to in your request 
including consultation with relevant departmental officers and searches of 
departmental file management systems. 
 
I am satisfied, on the basis of the consultation undertaken and the searches 
conducted, that the department does not hold any documents referred to in your 
request. 
 
As a consequence, relying on section 24A of the FOI Act, I cannot provide access to 
the documents you requested. 
 
FOI review rights 
 
If you are dissatisfied with my decision, you may apply for a review. 
 
Internal review 
 
Under section 54 of the FOI Act, you may apply in writing to the department for an 
internal review of my decision. The internal review application must be made within 
30 days of the date of this notice (or such further period as the department allows). 
To assist in the internal review process, please provide reasons you consider review 
of my decision is necessary. The internal review will be undertaken by another 
officer of the department within 30 days of receipt of your application.  
 
An application for an internal review can be sent to: 
Email: 
xxx@xxxxxx.xxx.xx 
Mail: 
FOI Unit (MDP 516) 
 
Department of Health  
 
GPO Box 9848 
 
CANBERRA ACT 2601 
 
Information Commissioner review 
 
Alternatively, under section 54L of the FOI Act, you may apply to the Office of the 
Australian Information Commissioner (OAIC) for review of my decision. An 
application for review must be made in writing within 60 days of this notice (if you 
do not request an internal review). 
 
You may also make a complaint to the OAIC about action taken by the department 
in relation to your application.  
 



The OAIC can be contacted by: 
 
Email: 
xxxxxxxxx@xxxx.xxx.xx 
 
Phone:  
1300 363 992 
 
More information about OAIC review and making a complaint is available on the 
OAIC website:  
https://www.oaic.gov.au/freedom-of-information/reviews/ 
 
Relevant provisions of the FOI Act 
 
The FOI Act, including the provisions referred to in this letter, can be accessed from 
the Federal Register of Legislation website:  
https://www.legislation.gov.au/Details/C2021C00382 
  
Contacts 
 
If you require clarification of any of the matters discussed in this letter you should 
contact the department’s Freedom of Information Unit on (02) 6289 1666 or at 
xxx@xxxxxx.xxx.xx.  
 
Yours sincerely 
 
 
 
 
 
Allison Jones 
A/g Assistant Secretary 
Science and Investment Branch 
COVID-19 Vaccine Taskforce 
 
20 December 2021